FcRn Therapies 2021 Conference: Humanized Mouse Models to Assess the In Vivo Efficacy of Antibody Therapeutics
Learn about the powerful models of Humanized mouse in IL4/IL4RA and IL-17 mice in various in-vivo settings
Read more
AET Europe 2020: Advancing Therapeutic Antibody discovery using RenMab/RenLite/RenMab KO immunoglobulin humanized mouse platforms
To meet the expanding needs of the therapeutic antibody market, Biocytogen established first and second generation of immunoglobulin humanized mouse platforms: RenMab, RenMab KO and RenLite.
Read more
IO Summit Boston: Improve Translation of Humanized Animal Models for Immunotherapy
Learn about the new developments in humanized animal models to get ideas on how models can be applied to solve specific translational challenges.
Read more
Accelerating Therapeutic Antibody Discovery with Three Distinct Humanized Mouse Models
With a robust immune response, RenMab™ Mouse produces fully-human, functional antibodies of high antigen specificity and diverse epitopes.
Read more
The use of genetically modified mouse models and in vitro cell culture models
Here we introduce a new screening strategy for antibody drugs, by which not only can people minimize the risk of potential “red flags”, but also reduce the time and cost.
Read more
Humanized Animal Models for Immunotherapy
Development and application of humanized animal models, which mimic human immunity and therapeutic targets, may provide promising solution to the challenges of preclinical translation
Read moreWebinars Category
- Antibody Discovery
- Humanized Animal Models
- Others
